John Sundy
Chief Tech/Sci/R&D Officer bij PANDION THERAPEUTICS, INC.
Profiel
John Sundy is currently the Chief Medical Officer at Pandion Therapeutics, Inc. Prior to this, he was the Senior Vice President at Gilead Sciences, Inc. from 2014 to 2020.
Before that, he was an Associate Professor at Duke University and Duke-NUS Graduate Medical School Singapore from 2006 to 2014.
Dr. Sundy received his undergraduate degree from Bucknell University and his doctorate from Drexel University College of Medicine.
Actieve functies van John Sundy
| Bedrijven | Functie | Begin |
|---|---|---|
| PANDION THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-05-2020 |
Eerdere bekende functies van John Sundy
| Bedrijven | Functie | Einde |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-04-2020 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01-01-2014 |
| Duke-NUS Graduate Medical School Singapore | Corporate Officer/Principal | 01-01-2014 |
Opleiding van John Sundy
| Bucknell University | Undergraduate Degree |
| Drexel University College of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. BiotechnologyHealth Technology Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA. | Health Technology |
